These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6655585)

  • 1. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.
    Lang B; Newsom-Davis J; Prior C; Wray D
    J Physiol; 1983 Nov; 344():335-45. PubMed ID: 6655585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
    Prior C; Lang B; Wray D; Newsom-Davis J
    Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.
    Newsom-Davis J; Murray N; Wray D; Lang B; Prior C; Gwilt M; Vincent A
    Muscle Nerve; 1982; 5(9S):S17-20. PubMed ID: 6302493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG.
    Kim YI
    Muscle Nerve; 1986; 9(6):523-30. PubMed ID: 3016532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between end-plate size and transmitter release in normal and dystrophic muscles of the mouse.
    Harris JB; Ribchester RR
    J Physiol; 1979 Nov; 296():245-65. PubMed ID: 231101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.
    Kim YI; Lømo T; Lupa MT; Thesleff S
    J Physiol; 1984 Nov; 356():587-99. PubMed ID: 6520797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates.
    Cull-Candy SG; Miledi R; Trautmann A; Uchitel OD
    J Physiol; 1980 Feb; 299():621-38. PubMed ID: 6103954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tubocurarine on end-plate current rundown and quantal content during rapid nerve stimulation in the snake.
    Harborne AJ; Bowman WC; Marshall IG
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):479-90. PubMed ID: 3271621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.
    Fukunaga H; Engel AG; Lang B; Newsom-Davis J; Vincent A
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7636-40. PubMed ID: 6584877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome IgG: early morphologic effects and immunolocalization at the motor endplate.
    Engel AG; Fukuoka T; Lang B; Newsom-Davis J; Vincent A; Wray D
    Ann N Y Acad Sci; 1987; 505():333-45. PubMed ID: 3479929
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
    Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
    J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
    Xu YF; Hewett SJ; Atchison WD
    J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic changes of neuromuscular transmission in mice induced by passive transfer of plasma with anti-presynaptic membrane receptor antibodies from a patient with myasthenia gravis.
    Xu K; Shu XQ; Zhuo XL; Lu CZ
    J Peripher Nerv Syst; 1998; 3(2):103-9. PubMed ID: 10959243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
    Herrera AA
    J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromuscular transmission and correlative morphology in young and old mice.
    Banker BQ; Kelly SS; Robbins N
    J Physiol; 1983 Jun; 339():355-77. PubMed ID: 6310088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.